DMP 525

Drug Profile

DMP 525

Alternative Names: 111In-IgG; Macroscint

Latest Information Update: 21 Jan 2008

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Ortho-McNeil
  • Class Heavy metals; Radiopharmaceuticals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Infections

Most Recent Events

  • 08 Oct 2001 No-Development-Reported for Diagnostic imaging in USA (Unknown route)
  • 23 Nov 1999 A study has been added to the therapeutic trials section
  • 22 Oct 1999 Two studies have been added to the therapeutic trials section ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top